These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Estramustine phosphate therapy in poorly differentiated carcinoma of the prostate.
    Author: Edsmyr F, Esposti PL, Andersson L.
    Journal: Scand J Urol Nephrol Suppl; 1980; 55():139-42. PubMed ID: 6938017.
    Abstract:
    Ninety patients with poorly differentiated prostatic carcinoma have been treated with Estramustine phosphate (Estracyt). Seventeen of them had clinically metastases and had had no previous therapy. Seventy-three were initially given oestrogens and/or irradiation. Objective response was observed in 59%. The best effect was seen in patients primarily untreated.
    [Abstract] [Full Text] [Related] [New Search]